C. Serby

发表

Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.

M. Littner, D. Tashkin, S. Menjoge, 2000, American journal of respiratory and critical care medicine.

The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.

P. Dorinsky, S. Menjoge, T. Witek, 1999, Chest.

The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.

D. D. Briggs, R. Casaburi, J. Donohue, 2000, Chest.

Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity.

T. Witek, D. Hochrainer, S. Chodosh, 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Pathogens Compliance Directive The Combination of Ipratropium and Albuterol Optimizes Pulmonary Function Reversibility testing in Patients with COPD Outpatient

S. Menjoge, G. Ferguson, C. Reisner, 2022 .

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

R. Zuwallack, P. Jones, R. Casaburi, 2002, European Respiratory Journal.

TIOTROPIUM (BA 679) : PHARMACOLOGY AND EARLY CLINICAL OBSERVATIONS

T. Witek, B. Disse, J. Souhrada, 1999 .

Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.

S. Rennard, M. Ghafouri, P. A. Johnson, 1996, Chest.

Fenoterol in exercise-induced asthma. Effect of dose on efficacy and duration of action.

P. König, N. Hordvik, C. Serby, 1984, Chest.

Comparison of oral and inhaled metaproterenol for prevention of exercise‐induced asthma

P. König, P. Eggleston, C. Serby, 1981, Clinical allergy.

Extended Therapy WithIpratropium Is Associated WithImproved Lung Function inPatients WithCOPD* A Retrospective Analysis ofDataFromSeven Clinical Trials

S. Rennard, P. Johnson, C. Serby, 2017 .

Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group.

A. Buist, D. Auerbach, N. Gross, 1997, Chest.

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.

J. Wilson, D. Hilleman, S. Menjoge, 1999, Chest.

Clinical Investigations: COPDExtended Therapy With Ipratropium Is Associated With Improved Lung Function in Patients With COPD: A Retrospective Analysis of Data From Seven Clinical Trials

S. Rennard, M. Ghafouri, M. Friedman, 1996 .